Your browser doesn't support javascript.
loading
Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis.
Martignetti, John A; Tian, Lifeng; Li, Dong; Ramirez, Maria Celeste M; Camacho-Vanegas, Olga; Camacho, Sandra Catalina; Guo, Yiran; Zand, Dina J; Bernstein, Audrey M; Masur, Sandra K; Kim, Cecilia E; Otieno, Frederick G; Hou, Cuiping; Abdel-Magid, Nada; Tweddale, Ben; Metry, Denise; Fournet, Jean-Christophe; Papp, Eniko; McPherson, Elizabeth W; Zabel, Carrie; Vaksmann, Guy; Morisot, Cyril; Keating, Brendan; Sleiman, Patrick M; Cleveland, Jeffrey A; Everman, David B; Zackai, Elaine; Hakonarson, Hakon.
Afiliação
  • Martignetti JA; Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA; Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029, USA; Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA. Electronic address: john.martignetti@mssm.edu.
Am J Hum Genet ; 92(6): 1001-7, 2013 Jun 06.
Article em En | MEDLINE | ID: mdl-23731542
ABSTRACT
Infantile myofibromatosis (IM) is a disorder of mesenchymal proliferation characterized by the development of nonmetastasizing tumors in the skin, muscle, bone, and viscera. Occurrence within families across multiple generations is suggestive of an autosomal-dominant (AD) inheritance pattern, but autosomal-recessive (AR) modes of inheritance have also been proposed. We performed whole-exome sequencing (WES) in members of nine unrelated families clinically diagnosed with AD IM to identify the genetic origin of the disorder. In eight of the families, we identified one of two disease-causing mutations, c.1978C>A (p.Pro660Thr) and c.1681C>T (p.Arg561Cys), in PDGFRB. Intriguingly, one family did not have either of these PDGFRB mutations but all affected individuals had a c.4556T>C (p.Leu1519Pro) mutation in NOTCH3. Our studies suggest that mutations in PDGFRB are a cause of IM and highlight NOTCH3 as a candidate gene. Further studies of the crosstalk between PDGFRB and NOTCH pathways may offer new opportunities to identify mutations in other genes that result in IM and is a necessary first step toward understanding the mechanisms of both tumor growth and regression and its targeted treatment.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miofibromatose / Mutação de Sentido Incorreto / Receptor beta de Fator de Crescimento Derivado de Plaquetas / Genes Dominantes Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miofibromatose / Mutação de Sentido Incorreto / Receptor beta de Fator de Crescimento Derivado de Plaquetas / Genes Dominantes Idioma: En Ano de publicação: 2013 Tipo de documento: Article